Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
934.8 DKK | -0.28% | +3.49% | +33.91% |
05-23 | Germany's Gerresheimer to acquire Blitz LuxCo for $866 mln | RE |
05-23 | Novo Nordisk's Weekly Insulin Flagged for Low Blood Sugar Risk | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.91% | 603B | |
+38.69% | 728B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+16.02% | 244B | |
+7.71% | 207B | |
-5.60% | 205B | |
-0.35% | 163B | |
+6.42% | 164B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Novo Nordisk Says Phase 3a Trial of Once-Weekly Insulin Icodec Met Primary Endpoint